Generate Biomedicines, Inc. GENB
NASDAQ · United States · Health Technology
$14.19-0.83 (-5.56%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.52 | -0.51 | -2.3% | $6.31M | +19.1% | -1.0%$14.49→$14.35 |
| Q1 2026 | 2026-05-07 | -1.07 | -0.48 | -122.9% | — | — | -10.7%$15.30→$13.66 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.